Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.

Mexichem Fluor SA de CV manufactures hydrofluoric acid. The company is headquartered in San Luis Potosi, Mexico.

Sichuan Haisco Pharmaceutical Co., Ltd., established on 2003-09-29, Business scope includes licensed projects:pharmaceutical production;Drug import and export;Pharmaceutical commissioned production;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Import and export;Technology Import and Export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Olon is one of the largest European developers and manufacturers, supplying APIs for the pharmaceutical industry worldwide both, for Generic as well as for contract manufacturing. OLON owns 5 manufacturing sites in northern Italy (Rodano, Settimo Torinese, Garbagnate Milanese, Mulazzano and Dorno) with more than 800 employees while INFA Group, with more than 400 employees, has 2 manufacturing sites in Italy, Labochim and Sifavitor, and 1 in Spain, Derivados Químicos.

CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Chemo Research SL is a Spanish private company. The firm engages in research and development in natural sciences & techniques.

Part of Permira I.P. Ltd., Laboratorios Lesvi SA is a Spanish company located in Castelbisbal. The firm produces pharmaceutical products. On March 18, 2005 Invent Farma ehf acquired Laboratorios Lesvi SA.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Juye Jinyi Chemical Co., Ltd., established on 2010-10-29, Business scope includes Arbidol,Paliperidone,Incaterol,Amisulpiride,Inositol Phosphate,Tesofensin,Production and sales of hematoxylin pharmaceutical intermediates(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Crystal Pharma SA develops and manufactures API, hormones and steroids for the pharmaceutical industry. Its products include abiraterone, alcaftadine, deferasirox, desoximetasone, dexpramipexol, dorzolamide, eplerenone, everolimus, fesoterodine fumarate, indacaterol, levocabastine, olopatadine, pramipexole, ropinirole, sirolimus, solifenacin fumarate, solifenacin succinate and tamsulosin. The company was founded in 1991 and is headquartered in Boecillo, Spain.

Shanghai Fangyu Health Medicine Technology Co., Ltd., established on 2013-09-10, Business scope includes new pharmaceutical products,Health products,medical instruments,Diagnostic reagents,Research and development of pharmaceutical intermediates,and provide relevant technical advice,Technical Services,technology transfer. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Neuland Laboratories Ltd. manufactures and exports bulk pharmaceutical ingredients and intermediates for the generics industry. The firm engages in the research, development, and commercialization of active pharmaceutical ingredients and intermediates for the generics industry. It offers custom manufacturing solutions and synthetic peptides. The company was founded by Rama Mohan Rao Davuluri on January 7, 1984 and is headquartered in Hyderabad, India.

Chengdu Innodabo Pharmaceutical Technology Co., Ltd., established on 2007-12-04, Business scope includes chemicals,Technology development and transfer of biopharmaceuticals;Chemical product sales(Free of Hazardous Chemicals);Import and export,Technology Import and Export(law,Except where prohibited by administrative regulations;law,Operations can only be carried out after obtaining a license restricted by administrative regulations).

Nanjing Fine Chemical Co., Ltd., established on 2007-06-04, Business scope includes chemical product research and development,Sales and technical consultation,transfer,Serve;Biotechnology R&D;Self-operated and agent import and export business of various commodities and technologies(Except that the state restricts the company to operate or prohibits the import and export of commodities and technologies).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Orbicular Pharmaceutical Technologies Pvt Ltd. is an Indian private company located in Hyderabad. The firm engages in the development and licensing of complex pharmaceutical products. It was founded by M. S. Mohan and Hiren Patel. M. S. Mohan is currently the CEO of the company.\nThe company says this about itself: Orbicular Pharmaceutical Technoloqies is a Speciality Pharmaceutical Company engaged in the development and licensing of complex pharmaceutical products to global partners.

Shanghai Weizhi Pharmaceutical Technology Co., Ltd., established on 2006-07-19, Business scope includes biological,Technology development in the field of medical expertise,technical consulting,Technical Services,technology transfer,biological reagent(except medical,Diagnostic reagents),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)production and sales of,Engaged in the import and export of goods and technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]